Betulin, an important compound found in birch tree bark, can be converted to betulinic acid, an important pharmacological substance. Betulin has recently been reported as a cytotoxic agent for several tumor cell lines and as an apoptotic inductor. Angiogenesis is a key process involved in tumor metastasis and in developing tumor resistance to cytotoxic therapy. There are little data on betulin as an anti angiogenic agent. This preliminary study aimed to evaluate the cytotoxic effect of betulin on three cancer cell lines: HeLa (cervix adenocarcinoma), MCF7 (breast adenocarcinoma) and A431 (skin epidermoid carcinoma), and the apoptotic mechanism, as well as the implication in the capillary formation of the chicken embryo chorioallantoic membrane. The analysis consisted in the interpretation of the MTT assay and fluorescence double staining with Hoechst dye 33258 and propidium iodide, while the angiogenic effect was evaluated using morphological and immunohistochemical techniques. The antitumor activity is revealed by the double fluorescence staining, indicating that at higher concentrations, the cell membrane permeability is enhanced, while at lower concentrations there is evidence for nuclear fragmentation. In what concerns its effect on the process of blood vessel formation, betulin induced the reduction of newly formed capillaries, especially in the mesenchyme, possible through targeting the normal function of endothelial cells. In vitro results proved the superior specificity of betulin on cervical cancer cells, followed by skin cancer cells.
Neoplasic disease represents nowadays a top priority in pharmaceutical research [1] . In order to develop, cancers require a source of nutrients and oxygen otherwise they cannot form masses greater than a few mm without developing central necrosis [2] . Neoplasms usually metastasize through the development of a network of local small blood vessels, a process called angiogenesis [2, 3] . An attractive option for treatment may consist of antiangiogenic therapy, which is less susceptible to lead to treatment resistance [4] . Antiangiogenic natural products may be used as complementary therapy that combines a multitude of complex structures with synergistic activity that may inhibit angiogenesis by multiple mechanisms and prevent cancer recurrence [5, 6] . Some studies suggest that only a few anticancer agents have the ability to target both tumor cells and cells of the vasculature (endothelial cells) and are potentially effective angiogenesis inhibitors [7] .
A promising group of compounds are pentacyclic triterpenes, among which are betulin and its oxidation product, betulinic acid [8, 9] . These compounds are found in numerous species, particularly Betula sp., and the betulin content can rise to more than 90% of the total isolated products [8, 10] . Previous studies detailed the betulinic acid antiangiogenic mechanism in the embryonated egg model [11] and its selective cytotoxicity [12] . The less studied betulin inhibits the rate of solid tumor growth [13] ; it was also used as an oleogel for the treatment of actinic keratoses that represent squamous cell carcinoma in situ [13, 14] . The interest in testing this compound resides in the fact that the precise mechanism of action is still unknown, some studies reporting its apoptotic activity [15, 16] .
Pentacyclic triterpenes were intensively analysed for their potential antiangiogenic effects [17] , but no conclusive data were formulated for betulin. The aim of our study was to analyze betulin's antiangiogenic activity with possible correlations to apoptosis and also its cytotoxic activity on tumor cell lines (HeLa, MCF-7, A431), including establishing a dose-effect relationship. The MTT-assay was performed in order to characterize the effect of betulin on the viability of a set of human adherent cell lines (A431, HeLa and MCF7). As shown in Figure 1 , betulin inhibited the cell growth in a concentration dependent manner.
The calculated IC 50 values for betulin were 6.76, 6.67 and 8.32 µM against A431, HeLa and MCF7 cells, respectively. These values indicate a similar activity of betulin on HeLa and A431 cell lines, comparable with the IC 50 value for MCF-7, which also previously proved to be a sensitive line to betulin [18] , even in small concentrations. Betulin is also active on other tumor cell lines [8] , as well as in skin pathology with cancerous evolution [19] . The present study confirms its antitumor in vitro activity and also reveals the possibility of new therapeutic approaches for cervix and skin carcinoma. Rzeski et al. [20] showed that low concentrations of betulin inhibited the migration of glioma (C6), lung carcinoma (A549) and medulloblastoma (TE671) cells, which suggest that betulin could be used as a chemopreventive agent for patients with increased risk of metastases in lung cancer. The in vitro evaluations represent only the first step before exploring the compound using in vivo models. Cell morphology and membrane integrity was characterized by means of the HOPI fluorescent double staining technique. HeLa, A431 and, more specifically, MCF-7 cells exposed to low concentrations of betulin (3-10 µM) exhibited a gradual nuclear condensation and fragmentation, as well as shrinkage, with no serious deterioration in the membrane integrity (Figures 2, 3, 4) .
A 24 hours exposure to betulin of the mentioned cell lines at 30 µM resulted in a substantial perturbation of cell membrane function, as evidenced by an intensive fluorescence of PI. The presented morphological findings are in good agreement with the apoptosis inducing capacity of the tested compound. The documentation of the developing in vivo CAM was achieved by photographing the vascularized membrane before and two days after the application of the samples. The CAM treated specimens were harvested on the 10 th day of incubation after 3 days of treatment, indicating a relatively low survival of the embryos. These experiments were performed in order to correlate the antitumor in vitro activity of betulin with in vivo observations. From the macroscopic images of betulin treated membranes a slight reduction of the capillary area inside the sterile ring is observed (Figures 5a, 5c ), compared with the membrane treated only with DMSO (Figures 5b, 5d ). Further data were obtained by analyzing the morphological and immunohistochemical staining. After 3 days of treatment, the tested betulin in 0.5% DMSO compared with the blank specimen did not induce any vascular damage visible on the CAM even if, compared with the blank control samples, the immature capillaries are not so numerous (Figures 6a, 6b , 6c, 6d). At the same time, the solvent (DMSO 0.5%, as control) showed only a more intense reduction in vascularization ( Figure 6b ). These observations can be correlated to the anti-inflammatory effect of betulin. At the same stage of the CAM evolution, the influence of the control samples applied in the same manner led to the following observations: blank control samples (ring only) did not seem to significantly disturb the rapid capillary growth (6a). For the sample treated with betulin in DMSO, a low number of FVIII positive vessels could be seen in the membrane stroma, while, under the epithelium, a higher number of immature vessels were noticeable, but the expression of the marker is diffuse (Figure 6d ). This indicates a possible target for the tested compound: the endothelial cell functionality. Compared with betulinic acid, which was proved in previous studies [21] to have an antiangiogenic activity dependent on some transcription factors overexpressed in tumors, betulin seems to develop a different antitumor mechanism. Regarding the smooth muscle actin, there was a normal expression in the mature vessels intima and an absence of this marker in the surroundings of capillaries and in the stromal mesenchyme, indicating that there is no change in the smooth muscle metabolism and consequently the maturation of the vessels is consistent with the stage of CAM evolution (6e).
In addition, for the evaluation of the antiangiogenic effect of betulin, a semi-quantitative technique was applied, using the hotspot method and a modified calculation formula for the antiangiogenic activity index. For the blank specimen (with plastic ring), an antiangiogenic index of 11.1% was found; the DMSO control specimen generated an index of 55.5%, while betulin in DMSO produced a reduction of the vessel density of 44.4%. Another study indicated for VEGF, the highest angiogenic cytokine, almost double the natural angiogenic activity reachable for the blank sample [22] . The low antiangiogenic activity for the sample with the plastic ring confirms its good tolerability, while the values indicated for betulin show a relative antiangiogenic effect and a low cytotoxicity at the vascular level. Betulin has not been considered, until recently, active as a cytotoxic agent [8] . The in vitro tests performed in the last few years indicate betulin as a selective cytotoxic agent on some tumor cells, acting through an indirect pathway triggering mitocondrial apoptosis, with limited side effects [15] . From our findings, betulin seems to be an agent targeting blood vessel endothelial cells, possibly through apoptosis, inducing the reduction of functional blood vessels in the high rate growing capillary plexus of the chicken embryo chorioallantoic membrane. Other structures that induce a similar effect have been reported [23] .
Cytotoxic effect of betulin
We can formulate a possible correlation between the apoptotic effect on HeLa cell culture of betulin and the modification induced by it in the rapid growing capillary plexus. The IC 50 was the lowest value for the same cell culture (6.67 M) compared with A431 and MCF7, indicating a higher potency against cervix carcinoma cells. At higher concentrations betulin manifested cell membrane disruption, which sustains its apoptotic effect. Betulin might target the apoptosis of the endothelial cell in the rapid proliferation stage as it is characteristic for the chick CAM blood vessel kinetics in the period between the 7 th and the 10 th day of incubation. Targeting the endothelial cell metabolism, betulin might be a potentially active compound that could be used in tumors with resistance to cytotoxic drugs, acting first on endothelial cells and rendering the tumor cells more vulnerable to apoptosis, with little toxicity for the host, as previously sustained by Folkman [24] . Its specific activity on tumor cells could be correlated with previous studies on skin carcinoma that proved its strong activity [25] .
In conclusion, betulin exhibits a more important specificity on breast cancer cells, even at a lower dosage, but also on cervix carcinoma and skin cancer. The apoptotic effect is revealed by the double fluorescence staining, showing that at a higher concentration, the cell membrane permeability is enhanced, while at lower concentration nuclear condensation is produced. The implication of betulin in the angiogenic process of blood vessel 984 Natural Product Communications Vol. 7 (8) 2012
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formation tested in vivo on the chick chorioallantoic membrane consisted in the reduction of newly formed capillaries, especially in the mesenchyme, by affecting the normal function of endothelial cells, but without any modification to the stromal architecture. This is in contrast to the related acid, betulinic acid, which affects stromal architecture. Consequently, betulin could act in a doserelated manner as both an apoptotic inductor of tumor cells and of tumor blood endothelial cells. All these data suggest the significant antineoplasic activity of betulin, which could be considered as a potential future anticancer agent.
Experimental

Materials:
Betulin was purchased from Sigma Aldrich (Taufkirchen, Germany, purity >98%), and DMSO from Fluka (Buchs, Switzerland). The latter was used in a concentration of 0.5% in distilled water to solubilize the low water soluble betulin for the purpose of the chorioallantoic membrane (CAM) assay. The stock solution of betulin for all tests was 10 mM.
MTT assay: Antiproliferative effects were measured in vitro on 3 human cell lines (ECACC; Salisbury, UK): HeLa (cervix adenocarcinoma), MCF7 (breast adenocarcinoma) and A431 (skin epidermoid carcinoma) with the MTT ([3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide]) assay [26] . The cells were cultivated in minimal essential medium supplemented with 10% fetal bovine serum, 1% non-essential amino acids and an antibioticantimycotic mixture. All media and supplements were obtained from PAA Laboratories (Pasching, Austria). The cells were grown in a humidified atmosphere of 5% CO 2 at 37°C. Cancer cells (5000/well) were seeded onto a 96-well microplate and attached to the bottom of the well overnight. On the second day, 200 μL of new medium containing the test substances was added. After incubation for 72 h, the living cells were assayed by the addition of 20 μL of 5 mg/mL MTT solution. MTT was converted by intact mitochondrial reductase and precipitated as blue crystals during a 4 h contact period. The medium was then removed, and the precipitated crystals were dissolved in 100 μL of dimethyl sulfoxide (DMSO) during a 60 min period of shaking. Finally, the reduced MTT was assayed at 545 nm, using a microplate reader; wells with untreated cells were utilized as controls. All in vitro experiments were carried out on 2 independent microplates with at least 5 parallel wells. The MTT evaluation was developed at the same time and the same preparation of cells. Stock solutions of the tested substances (10 mM) were prepared with DMSO and the highest DMSO concentration (0.3%) of the medium did not have any significant effect on the cell proliferation.
Hoechst dye 33258 and propidium iodide (HOPI) double staining:
The HOPI staining was performed according to the method described earlier [27] . Near confluent Hela, MCF-7 and A431 cells were seeded into a 96-well plate (5000 cells/well). After 24 h of incubation with test compounds Hoechst 33258 (HO) and propidium iodide (PI) were added to the culture medium to final concentrations of 5 μg/mL and 2 μg/mL, respectively. The cells were incubated for 1h at 37°C with the mixture of the Hoechst 33258 and propidium iodide and then were photographed by means of a Nikon Eclipse inverted microscope equipped with an epifluorescence attachment (Nikon Corp, Tokyo, Japan) containing the appropriate optical blocks and a MicroPublisher 3.3 RTV CCD camera (QImaging, Surrey, BC, Canada). The staining allowed the identification of live, early-apoptotic, late-apoptotic or necrotic cells. While HO permeates all the cells and makes the nuclei appear blue, the apoptosis was revealed with nuclear changes such as chromatin condensation and nuclear fragmentation. The necrotic and the late-apoptotic cells were identified as cells with PI uptake, which indicates loss of membrane integrity, staining cell nuclei red. The selective uptake of the 2 dyes allows distinction between apoptotic and necrotic cell death.
Chorioallantoic membrane (CAM) assay:
The fertilized chicken (Gallus gallus domesticus) eggs were incubated at 37 o C, at constant humidity. In order to reveal the developing vascularized chorioallantois, on day 3 of incubation, 3 mL of albumen were removed from the sharper end of the egg and consequently, on the 4 th day of incubation, a window was cut into the shell; the disclosure was resealed with silk tape [28] . The in-shell study of the CAM was performed beginning with the 7 th day of incubation, applying 2 L of the samples (10 g/L betulin in 0.5% DMSO, and 0.5% DMSO alone, and sterile ring without any solution) each day onto the surface of the chorioallantoic membrane, in plastic sterile rings. All the samples were applied in triplicate. The membrane in formalin solution was harvested on the day of the embryo's death.
Morphological and immunohistochemical evaluation:
After the treatment, the harvested specimens of the chick embryo chorioallantoic membrane were fixed in buffered formalin solution (10%) for 24 h, then the membranes were paraffin embedded. Each specimen was cut into slices of 5 μm in thickness with the aid of a microtome. The morphological analysis was carried out on sections using haematoxylin and eosin (H&E) staining. For the imunohistochemical (IHC) evaluation the sections were incubated with the anti-smooth muscle actin (Act), anti-factor VIII (F VIII) antibodies. Secondary antibody labeled with horse-radish peroxidase was added and the tissues were stained with 3, 3'-diaminobenzidine (DAB) as a chromogen and modified Lille's haematoxylin as a counterstain. The whole IHC assay was performed with a Dako Cytomation Auto Stainer (Dako, Glostrup, Denmark).
Microscopic and photographic technique of CAM specimens:
Macrophotographs of the CAM in evolution, in ovo, were taken using a stereomicroscope (Zeiss Stemi DV4 SPOT) with a Sony Cybershot camera, while microphotographs were taken with a Nikon Eclipse E600. Lucia G software system was used for the processing of all images.
Evaluation of the angiogenesis process:
The reduction of the number of capillaries in the area of application was observed by analyzing the photographs of the in vivo CAM during the experiment and was confirmed by the microscopic evaluation of membrane sections. Semi-quantitative techniques were applied for the measurement of the angiogenic process in response to betulin. The hot-spot method was used to identify the areas with an impaired angiogenesis [29] . Morphological analysis on the H&E sections, at x20 magnification, was conducted on 3 areas with abnormal vascular plexus of the chorioallantoic membrane. The immunostained sections were evaluated using the same hot spot method, using FVIII antibody as a marker for the endothelial cells and SMA as a marker for muscle type peri-endothelial cells (smooth muscle cells, perycites) and for myofibroblasts in the stromal area.
Three hot-spot areas were chosen and the blood vessels were counted by 2 different observers, both for the betulin preparations and for the blank samples. The mean value was used to calculate the antiangiogenic activity:
Antiangiogenic activity % = [1 -Number of vessels (samples)/number of vessels (blank)] x 100
